AI SERVING
CARDIOLOGY

YOUR AI PARTNER FOR MORE EFFICIENT CARDIAC DIAGNOSTICS

INNOVATIVE
ANALYSIS SOLUTION

COMBINING CLINICAL RIGOR WITH DATA SCIENCE EXPERTISE AND DESIGN SENSE

Cutting edge
technology

Leveraging the latest machine learning and cloud computing technologies

Making a
difference

Always looking for mission-driven exceptional talent

ABOUT CARDIOLOGS

Our mission is to democratize access to expert cardiac care through medical-grade artificial intelligence and cloud technology.

Founded in 2014, we are a medical technology company committed to making cardiac diagnostics scalable and accessible to everyone, by creating solutions for clinicians to face the ever-increasing demand for diagnostics.

We partnered with leading cardiology and emergency medicine experts to develop cutting-edge solutions that empower clinicians worldwide to deliver expert cardiac care faster and more efficiently.

Our Cardiologs ECG Analysis Solution is a unique arrhythmia diagnostic software, cloud-based, device-agnostic and powered by medical-grade Artificial Intelligence to streamline electrocardiogram analysis.

It is the world’s first medical device powered by deep learning technology to have the CE mark and amongst the first to receive the FDA clearance.

Built on an ever-growing and proprietary database of more than 10,000,000 recordings, it is supported by a number of clinical publications that demonstrate leading diagnostic performance. Today, the Cardiologs ECG Analysis solution is being used every day used daily by clinicians and healthcare practitioners across 4 continents.

Swipe Left Below
About Cardiologs
Cardiologs Founded
April 2014

October 2015
First Patent Filing
CE Mark
August 2016

June 2017
FDA Clearance
Seed Fundraising
July 2017

January 2018
US Commercial Launch
About Cardiologs

Unparalleled Efficiency Gains

About Cardiologs

ANALYSIS TIME:
6 MINUTES

Holter Processing Time (Minutes)

Experience on Platform

Standard Holter
Recordings

Cardiologs Holter
Analysis Solution

About Cardiologs
About Cardiologs

* Internal Cardiologs data on file (ref. C-DOC01: Cardiologs Holter Analysis Solution Efficiency Gains)

PRODUCT

MEDICAL GRADE ARTIFICIAL INTELLIGENCE

  • Solution CE Marked and FDA cleared as a decision-support aid for arrhythmia diagnostics
  • Platform supports broad range of ECG recording modalities, including traditional and extended Holters
PIONEER IN MEDICAL ARTIFICIAL INTELLIGENCE

Cardiologs was the first company to receive the CE Mark for a medical device based on deep learning technology, and is the first and only cleared deep-learning enabled solution for ECG analysis

*Please refer to the Instructions For Use for a list of the technical requirements needed for compatibility.

CLINICALLY VALIDATED AI ENGINE FOR MORE EFFICIENT CARDIAC DIAGNOSTICS

  • Artificial Intelligence platform capable of identifying all clinically relevant arrhythmias and 100+ cardiac abnormalities on 12-lead ECG*
  • Industry-leading algorithm performance supported by a number of clinical publications
AI ALGORITHM ACCURACY DRIVING DIAGNOSTIC EFFICIENCY

The Cardiologs platform has been shown to reduce by 20X the false positive rate in detection of Atrial Fibrillation with 96.8% sensitivity and 99.2% specificity

FLEXIBLE AND SCALABLE CLOUD-BASED SOLUTION

  • Workflow and report format customizable to the demands of your organization
  • Patent-pending user interface specifically designed to improve Holter analysis efficiency
  • Complete cloud-based Holter analysis solution that scales with your organization and does not require any local software installation
SERIOUS ABOUT PATIENT PRIVACY AND DATA COMPLIANCE

The Cardiologs cloud infrastructure is fully compliant with local data and patient privacy regulations, including hosting on a HIPAA compliant Microsoft Azure server in the US

CUSTOMER TESTIMONIALS

Testimonial

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi sagittis vehicula metus at volutpat. Ut placerat, orci sed vestibulum auctor, augue.

Joe Bloggs, CEO Company Name

Testimonial

Morbi sagittis vehicula metus at volutpat. Ut placerat, orci sed vestibulum auctor, augue.

Jane Smith, CEO Company Name

Testimonial

Ut placerat, orci sed. Vestibulum auctor, augue agittis vehicula metus. Placerat auctor sed ut volutopat.

Matt Brown, CEO Company Name

Testimonial

Morbi sagittis vehicula metus at volutpat. Ut placerat, orci sed vestibulum auctor, augue.

Laura Jones, CEO Company Name

OUR LEADERSHIP TEAM

Yann Fleureau

Co-Founder, CEO

+ Read Yann's Bio
Jia Li

Co-Founder, Science

+ Read Jia's Bio
Gaëlle Salaün

Regulatory & Quality

+ Read Gaëlle's Bio
Chiara Scabellone

Product

+ Read Chiara's Bio
Romain Pomier

Technology

+ Read Romain's Bio
Nicolas Godin

Finance & Operations

+ Read Nicolas's Bio
Christine Henry

VP Clinical Affairs

+ Read Christine's Bio
Laurent Fiorina

Medical Expert

+ Read Laurent's Bio

PARTNERS

PRESS RELEASES & NEWS

Swipe Left Below

New Study Published in JACC Clinical EP Validates that Cardiologs’ AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for AFib

PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in collaboration with Valley Health System…

READ FULL
PRESS RELEASE to article

Rick Anderson and Mark Toland Join Cardiologs’ Board of Directors

PARIS and BOSTON, Oct. 7, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, announced today that it has appointed two veteran medical device industry executives to the company’s board…

READ FULL
PRESS RELEASE to article

Cardiologs Partners with MicroPort CRM to Distribute its AI-based Cardiac Diagnostics Solution in France

The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders. BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global…

READ FULL
PRESS RELEASE to article

Clinical Study Shows Cardiologs’ AI Reduces The False Positive Burden Of Implantable Loop Recorders By Almost 70%

Data presented at HRS 2020 shows Cardiologs’ AI-system successfully eliminates more than two-thirds of atrial fibrillation false positives from ILR reports, alleviating the clinical burden associated with remote monitoring PARIS…

READ FULL
PRESS RELEASE to article

Cardiologs Announces Clinical Study to Monitor Cardiac Safety of COVID-19 Patients Via Smartwatches

Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatment BOSTON, April 22, 2020 /PRNewswire/ — Cardiologs, a…

READ FULL
PRESS RELEASE to article

Cardiologs Raises $15 Million in Series A Funding Led by Alven

Funding will accelerate adoption of the company’s breakthrough AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities PARIS and BOSTON, Jan. 10, 2020 /PRNewswire/ — Cardiologs, a global leader…

READ FULL
PRESS RELEASE to article

COMPANY CULTURE

Welcome to Cardiologs!

Our beautiful Paris offices are centrally located in a loft space with conservatory roofing.

Within brick walls, wooden floors and greenery we created a welcoming, comfortable work space, and an atmosphere of innovation, communication and trust. Our open space boasts an impressive organic table instead of a classic rectangle, enabling close collaboration.

We believe in what we do, and what we do matters.

We are a tight-knit team and we nurture our company culture with monthly all-hands meetings and apéros, weekly yoga classes, climbing activities, daily coffee breaks in our comfy kitchen, but most importantly, we have each other’s backs.

Keen to get involved? We would like to hear from you!

VIEW ALL AVAILABLE POSITIONS to careers